Clinical Trials Logo

ACE Inhibitors clinical trials

View clinical trials related to ACE Inhibitors.

Filter by:
  • None
  • Page 1

NCT ID: NCT04367883 Recruiting - COVID19 Clinical Trials

Influenza Vaccination, ACEI and ARB in the Evolution of SARS-Covid19 Infection

Start date: March 1, 2020
Phase:
Study type: Observational

Some authors have proposed the use of the flu vaccine to reduce the severity of COVID-19 cases, while some have proposed the use of ACE Inhibitors (ACEI) or Angiotensin Receptor blockers (ARB), since this virus shares hemagglutinin as a transmission mechanism and acts on the ACE2 enzyme during infection. The aim is to evaluate whether the admitted patients who are previously vaccinated or those who were already receiving treatment show a better evolution.